NDAORALCAPSULE
Approved
Mar 2020
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
2
Clinical Trials (2)
Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ Study
Started Aug 2024
0Ulcerative Colitis
A Study Investigating the Utilization, Effectiveness and Quality of Life in Clinical Practice in Germany for Participants With Relapsing-remitting Multiple Sclerosis Treated With Ozanimod (Zeposia®)
Started Mar 2021
450 enrolled
Multiple Sclerosis, Relapsing-Remitting
Loss of Exclusivity
LOE Date
Sep 30, 2038
153 months away
Patent Expiry
Sep 30, 2038
Exclusivity Expiry
Aug 30, 2027